Oct 8 (Reuters) – The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines – AstraZeneca blood pressure drug succeeds in late-stage trial – UK pledges to defend steel industry after EU says it will raise tariffs to 50% – Ex-KPMG auditor fined for third time in four years for 'serious breaches' – Jaguar Land Rover to restart UK production after devastating cyber attack Overview – AstraZeneca's new blood pressure drug succeeded in a late-stage trial, setting the stage for regulatory approval it forecasts could generate up to $5 billion in annual sales. – Britain vowed to protect its steel industry from "unfair behaviours", as the EU proposed raising steel import tariffs from 25% to 50% and cutting duty-free quotas. – Britain's accountancy regulator fined former KPMG partner Anthony Sykes 51,187 pounds ($68,549.63) for "serious breaches" of international standards in the firm's 2022 audit of retailer N Brown. – Jaguar Land Rover, owned by India's Tata Motors, will resume key UK manufacturing operations on Wednesday after a month-long halt triggered by a cyber attack on August 31. ($1 = 0.7467 pounds) (Compiled by Bengaluru newsroom)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
